Keros Therapeutics logo
Keros Therapeutics KROS
$ 61.86 3.19%

Quarterly report 2024-Q2
added 08-07-2024

report update icon

Keros Therapeutics ROA Ratio 2011-2024 | KROS

Annual ROA Ratio Keros Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-41.35 -34.12 -23.01 -16.84 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-16.84 -41.35 -28.83

Quarterly ROA Ratio Keros Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-43.0 -43.58 -31.93 -41.24 -38.46 -38.22 -29.88 -38.71 -27.94 -34.35 -21.41 -25.87 -21.51 -19.09 -12.87 -45.27 -73.2 -95.25 -87.49 -87.49 -55.1 -29.06 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-12.87 -95.25 -42.77